BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29739071)

  • 1. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
    Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
    Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
    Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
    Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis.
    Wang JL; Su WY; Lin YW; Xiong H; Chen YX; Xu J; Fang JY
    Oncotarget; 2017 Feb; 8(8):12866-12876. PubMed ID: 28030817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer.
    Liu Y; Wu T; Lu D; Zhen J; Zhang L
    Int J Biol Markers; 2018 Aug; 33(3):308-313. PubMed ID: 29683068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.
    Zhao Y; Dai C; Wang M; Kang H; Lin S; Yang P; Liu X; Liu K; Xu P; Zheng Y; Li S; Dai Z
    Oncotarget; 2016 Sep; 7(39):62966-62975. PubMed ID: 27542234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
    Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
    Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis assessment of CD44
    Gu J; Chen D; Li Z; Yang Y; Ma Z; Huang G
    Arch Gynecol Obstet; 2022 Oct; 306(4):1147-1160. PubMed ID: 35435483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
    Wu JX; Zhao YY; Wu X; An HX
    PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis.
    Li G; Zhou Z; Zhou H; Zhao L; Chen D; Chen H; Zou H; Qi Y; Jia W; Pang L
    Future Oncol; 2017 Oct; 13(23):2103-2118. PubMed ID: 28984154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
    Zu G; Ji A; Zhou T; Che N
    Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 gene polymorphism--a novel prognostic factor in esophageal cancer.
    Sadot E; Kraus S; Stein M; Naboishchikov I; Toledano O; Kazanov D; Arber N; Kashtan H
    Int J Biol Markers; 2014 Mar; 29(1):e49-54. PubMed ID: 24474454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
    Yuan H; Tu SL; He XJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 overexpression in cancer development and progression: a meta-analysis.
    Lee JH; Kim SH; Lee ES; Kim YS
    Oncol Rep; 2009 Nov; 22(5):1149-56. PubMed ID: 19787233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.